NM_001004748.1:c.622C>G

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_001004748.1(OR51A2):​c.622C>G​(p.Leu208Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,426,154 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0000085 ( 0 hom., cov: 17)
Exomes 𝑓: 0.000011 ( 2 hom. )

Consequence

OR51A2
NM_001004748.1 missense

Scores

18

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -11.1

Publications

1 publications found
Variant links:
Genes affected
OR51A2 (HGNC:14764): (olfactory receptor family 51 subfamily A member 2) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
MMP26 (HGNC:14249): (matrix metallopeptidase 26) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.023356318).
BP6
Variant 11-4955092-G-C is Benign according to our data. Variant chr11-4955092-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 3411377.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OR51A2NM_001004748.1 linkc.622C>G p.Leu208Val missense_variant Exon 1 of 1 ENST00000380371.1 NP_001004748.1 Q8NGJ7A0A126GWD5
MMP26NM_021801.5 linkc.-144-32976G>C intron_variant Intron 2 of 7 ENST00000380390.6 NP_068573.2 Q9NRE1
MMP26NM_001384608.1 linkc.-152-33178G>C intron_variant Intron 2 of 7 NP_001371537.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OR51A2ENST00000380371.1 linkc.622C>G p.Leu208Val missense_variant Exon 1 of 1 6 NM_001004748.1 ENSP00000369729.1 Q8NGJ7
MMP26ENST00000380390.6 linkc.-144-32976G>C intron_variant Intron 2 of 7 5 NM_021801.5 ENSP00000369753.1 Q9NRE1
MMP26ENST00000300762.2 linkc.-152-33178G>C intron_variant Intron 2 of 7 1 ENSP00000300762.2 A0A8J8YUH5

Frequencies

GnomAD3 genomes
AF:
0.00000848
AC:
1
AN:
117960
Hom.:
0
Cov.:
17
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000971
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000269
AC:
6
AN:
222884
AF XY:
0.0000331
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000143
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000998
Gnomad OTH exome
AF:
0.000181
GnomAD4 exome
AF:
0.0000107
AC:
14
AN:
1308084
Hom.:
2
Cov.:
34
AF XY:
0.00000613
AC XY:
4
AN XY:
653040
show subpopulations
African (AFR)
AF:
0.0000313
AC:
1
AN:
31958
American (AMR)
AF:
0.0000818
AC:
3
AN:
36664
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24330
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34302
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81808
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48800
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5486
European-Non Finnish (NFE)
AF:
0.0000101
AC:
10
AN:
989722
Other (OTH)
AF:
0.00
AC:
0
AN:
55014
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.580
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000847
AC:
1
AN:
118070
Hom.:
0
Cov.:
17
AF XY:
0.0000175
AC XY:
1
AN XY:
57068
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
35426
American (AMR)
AF:
0.0000970
AC:
1
AN:
10312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2752
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3836
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3918
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
248
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52314
Other (OTH)
AF:
0.00
AC:
0
AN:
1548
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000936
Hom.:
0
ExAC
AF:
0.00000891
AC:
1

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Oct 01, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
0.0010
DANN
Benign
0.36
DEOGEN2
Benign
0.0024
T
Eigen
Benign
-2.6
Eigen_PC
Benign
-2.7
FATHMM_MKL
Benign
0.0018
N
LIST_S2
Benign
0.034
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.023
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-1.0
N
PhyloP100
-11
PROVEAN
Benign
0.57
N
REVEL
Benign
0.11
Sift
Benign
0.58
T
Sift4G
Benign
0.27
T
Polyphen
0.0
B
Vest4
0.029
MutPred
0.55
Loss of stability (P = 0.2295);
MVP
0.51
MPC
1.1
ClinPred
0.030
T
GERP RS
-6.0
Varity_R
0.032
gMVP
0.058
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs547433825; hg19: chr11-4976322; API